Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune

Related Experiment Video

Updated: Jun 10, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Sara Samimi1, Bernice Benoit, Katherine Evans

  • 1Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. samimi@mail.med.upenn.edu

Archives of Dermatology
|August 18, 2010
PubMed
Abstract

Insights

Programmed death-1 (PD-1) is elevated on T cells in Sézary syndrome, a type of cutaneous T-cell lymphoma. Blocking PD-1 may improve immune function and offers a potential targeted therapy for patients.

Area of Science:

  • Immunology
  • Dermatology
  • Oncology

Background:

  • Cutaneous T-cell lymphoma (CTCL) encompasses Sézary syndrome and mycosis fungoides.
  • T-cell dysfunction is a hallmark of advanced CTCL.
  • Programmed death-1 (PD-1) is an immune checkpoint receptor implicated in T-cell exhaustion.

Purpose of the Study:

  • To investigate PD-1 expression on T cells in CTCL patients.
  • To explore mechanisms of PD-1 upregulation.
  • To assess the therapeutic potential of PD-1 blockade.

Main Methods:

  • Translation research study conducted at a university medical center.
  • Flow cytometry used to measure PD-1 expression on T cells.
  • Enzyme-linked immunosorbent assay (ELISA) used to quantify interferon-gamma (IFN-γ) production.

Main Results:

  • Significantly increased PD-1 expression observed on CD4(+) T cells in Sézary syndrome compared to mycosis fungoides and healthy controls.
  • PD-1 upregulation was induced by T-cell receptor engagement.
  • Blockade of PD-1/PD-L1 signaling enhanced IFN-γ production in some patients.
  • Longitudinal analysis showed decreased PD-1 expression correlating with clinical improvement.

Conclusions:

  • Elevated PD-1 expression on T cells in Sézary syndrome contributes to immune suppression.
  • Targeting the PD-1 pathway represents a potential therapeutic strategy for CTCL.
  • Further research into PD-1 blockade may offer new treatment options for patients.

More Related Videos

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes12:12

Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes

Published on: June 16, 2011

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview